Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car
Exerting Control Over Prejudiced Responses
Correlate Changes Between Lps & Antibiotic Resistance in Burkholderia Cepacia
Mechanisms Underlying Synapse Formation & Elimination
Predictors of Oral Health in African Americans
Recently added grants:
Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade Gliomas
Shared Resource 04 Cancer Proteomics
Molecular Dissection of Seizure Microenvironment in Malignant Glioma
Shared Resource 05: Collaborative Functional Genomics
Molecular targeted radiotherapy to overcome resistance to in situ cancer vaccination
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-005
Application #
7329501
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant